作者
Atharv Kandale*, Mayuri Bhadalekar, Harshad Mane, Dr. Nilesh Chougule
摘要
DNA origami has emerged as a highly programmable and structurally adaptable framework for next-generation drug delivery systems within the field of nanomedicine. Utilizing precise base-pairing interactions, lengthy single-stranded DNA scaffolds may be folded into specified nanoscale designs with the aid of several short “staple” strands. These structures demonstrate outstanding biocompatibility, structural tunability, and molecular recognition ability, enabling targeted, stimuli-responsive, and high-efficiency therapeutic administration. DNA origami nanocarriers have been examined for the encapsulation, conjugation, or intercalation of anticancer medicines, nucleic acids, proteins, and immunomodulatory substances. Their programmable surfaces allow cell-specific targeting from ligand functionalization and regulated release triggered by pH, enzymes, light, or chemical signals. Despite promising potential, difficulties such as nuclease degradation, high production cost, immunological activation, and scaling restrictions remain impediments to clinical translation. Rapid advancements including chemically stable DNA nanostructures, hybrid nanocarriers, autonomous logic-gated systems, and in vivo imaging-guided delivery are gradually tackling these challenges. This paper gives a complete overview of DNA origami principles, structural classes, drug loading methods, biological applications, limits, and future possibilities. The talk stresses the revolutionary significance of DNA nanotechnology in generating precise, customized, and least hazardous drug delivery systems for next-generation therapeutic interventions.